Implementation of a Micro Bioreactor System for Platform Cell Culture Process Development at Cobra Biologics

Similar documents
Scaling Down Bioreactor Process Development: Comparison of Microbioreactor and Bench Scale Solutions.

Process Robustness & Challenges to Demonstrating Compliance

A Case Study on the Application of Disposable Technologies in cgmp Manufacturing Processes for a Therapeutic Antibody.

Biologics. Biologics. The Centre for Process Innovation. From innovation to commercialisation

Efficient and controlled expansion of IgG1 producing CHO-DG44 cells using the ActiCHO Media System and WAVE Bioreactor

From gene to manufacturing: Application of efficient cell line development strategies to deliver reliable, high quality biomanufacturing processes

Recombinant Antibody Production in Therapeutic Antibody Projects. Keshav Vasanthavada Senior Marketing Specialist, GenScript April 7, 2016

Manufacturing Integrated Biologics Manufacturing

APPROACHES TO IMPROVING THE PERFORMANCE OF MAMMALIAN CELL CULTURES FOR PROTEIN PRODUCTION

One-step seed culture expansion from one vial of high-density cell bank to 2000 L production bioreactor

Automation Supporting Single Cell Cloning Experiments and QbD-Based Bioprocess Development

Hollow Fiber Bioreactors: Single-Use. Perfusion. Scalable. Continuous Manufacturing.

Thermo Scientific HyClone Single-Use Bioreactor Products and Capabilities. Discovery Development Production

Entry Level Assessment Blueprint Biotechnology

Transduction of an Antibiotic Resistance Gene. Background

Driving Value through Innovation in Biotech Manufacturing. Agenda

Case study: Tech transfer of mammalian cell culture process from lab scale to production scale using disposable technology

We Know Bioprocessing

Scale-up & scale-down between the two. worlds of shaken and stirred bioreactors

BalanCD HEK293 SYSTEM

TransIT-PRO Transfection Reagent Protocol for MIR 5740 and 5750

NEW! CHOgro Expression System

FRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME INTEGRATED PRODUCTION PLATFORMS GMP-COMPLIANT PRODUCTION OF BIOPHARMACEUTICALS

ExpiCHO Expression System

Avalanche -Omni Transfection Reagent

Job Ready Assessment Blueprint. Biotechnology. Test Code: 4075 / Version: 01. Copyright 2014 NOCTI. All Rights Reserved.

Advanced Microbial Protein Expression

Instructions for use

Simulating Process Limitations in Microbial Cultivation: A Parallel Two-Compartment Scale-Down Approach

PRAXIS. A publication by Bioengineering AG

CSL s Large Scale Cell Culture Facility

****** Competition ELISA Kit Instruction

ClonaCell -CHO. Semi-Solid Cloning Testing Guidelines

MabSelect PrismA. gelifesciences.com/bioprocess

Single-use technology in downstream unit operations

In the biopharmaceutical industry,

ProSep Ultra Plus Chromatography Media

Cell Culture Flasks DATA SHEET

RoboLector Automated Fermentation. High-Throughput Real-Time Monitoring Scalability Automation

CloneMedia-CHO Semi-solid media for the growth of CHO-S Colonies

Scale-Up Solutions for Cell Therapy and. Bioprocess

Inspiring Advances in Bioprocessing. John Bonham-Carter March 14, 2017

Continuous Processing Progress in Manufacturing

CHOgro Expression System

Your Guide to Upstream Processing Solutions From Research to Production

Preparing Cell Cultures of Human Embryonic Kidney

Cultivation of sensitive cell lines - Improving bioreactor performance by dynamic membrane aeration

BioLector I 48 Parallel Microbioreactors. High-Throughput Real-Time Monitoring Scalability Automation.

CloneSelect Imager. Objective, quantitative assessment of cell growth

Human Bordetella Pertussis IgG ELISA kit

MagSi Beads. Magnetic Silica Beads for Life Science and Biotechnology study

Preclinical Development Drugs. Darrin Cowley PhD Executive Director Amgen BioBoot Camp 2015

MOLECULAR GENETICS: TRANSFORMATION AND CLONING adapted by Dr. D. L. Vogelien

Simplicity is the key Continuous purification of monoclonal antibodies

Abstract. Materials and Methods. Introduction

INOS. Colorimetric Cell-Based ELISA Kit. Catalog #: OKAG00807

Recent Developments & Future Directions in the Production of Monoclonal Antibodies. Rob Noel Plasma Product Biotechnology Conference 2009, Menorca

2013 Protein BioSolutions, Inc. All rights reserved. page 1

Applications involving the ViroCyt Virus Counter in the production of various recombinant proteins

Design and characterisation of a parallel miniaturised bioreactor system for mammalian cell culture

ANCA Screen IgG ELISA Kit

Anti- Tissue Transglutaminase TTG IgG ELISA Kit

EQUIPMENTS & MATERIALS COMMONLY USED IN A LABORATORY

Protocol. High-throughput Transfection Protocol for GoClone Reporter Assays. Tech support: Luciferase Assay System

Bovine IgG ELISA Kit

OPtimum Growth Flasks

Application Note Cultivation of Suspension and Hybridoma Cells in CELLSTAR CELLreactor Tubes

SCHEDULE. Friday: Pet Investigations: Plate counts - how to know how many clones of your pet you have (pg. 9-10)

Lab Exercise 13: Growth Curve

Advance the potential of your cell culture Cedex Bio and Cedex Bio HT Analyzers

Bacterial Transformation and Protein Purification

Critical Analytical Measurements for Bioreactor Optimization. controlling an organism s chemical environment leads to consistent and

EGFR (Phospho-Ser695)

Your Analyte ELISA Kit Instruction

INTERFERin in vitro sirna/mirna transfection reagent PROTOCOL

Bacterial genetic exchange : Bacterial Transformation

Optimization Strategies of Expression Cell Line Construction to Reduce the Biological Drug Development Risk. Feng Gao, MD, PhD. AutekBio CO.

2.4 TYPES OF MICROBIAL CULTURE

Protocols for Neural Progenitor Cell Expansion and Dopaminergic Neuron Differentiation

3. Close the bottom end of the column and apply the packing device on top. Pump water through the upper adaptor to remove air.

Recombinant therapeutic protein

Chapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology

Subject Index. chromatography step, 125-

Get to your high-value clones faster with a complete hybridoma media solution

Transfection of CRISPR/Cas9 Nuclease NLS ribonucleoprotein (RNP) into adherent mammalian cells using Lipofectamine RNAiMAX

ReproRNA -OKSGM is a non-integrating, self-replicating RNA-based reprogramming vector for generating induced pluripotent stem (ips)

SAMPLE LITERATURE Please refer to included weblink for correct version.

INTERFERin sirna transfection reagent

The RNAi Consortium (TRC) Broad Institute

Improving Bioprocessing Productivity Through the Application of Single-Use Protein A Columns

The Biotechnology Education Company. Quantitative ELISA. Storage: See Page 3 for specific storage instructions EXPERIMENT OBJECTIVE:

Novel Technologies in Plasma Fractionation. Dieter Fassnacht

Automated Protocol for ANTI-FLAG High Sensitivity, M2 coated 96-well plate Using the Sciclone ALH 3000 Workstation (Caliper Life Sciences)

jetprime in vitro DNA & sirna transfection reagent PROTOCOL

Protocol. VeriKine TM Human Interferon Alpha Multi-Subtype Serum ELISA Kit

TransIT -LT1 Transfection Reagent

Evaluation of the genesig q16 quantitative PCR unit

Integrated reactor feeding system amino acid feedback control via online HPLC for productivity gains

Interview Questions. K: Marketing is not in the current plan. 6. Who will be using it? S: Undergrad students. 3rd-5 th years. Two professors.

SVANOVIR APV-Ab. Avian Pneumovirus Antibody Test

Transcription:

Implementation of a Micro Bioreactor System for Platform Cell Culture Process Development at Cobra Biologics Kristina Lae, Scientist, Cell Culture Cobra Biologics, Södertälje, Sweden

Cobra Biologics and Cobra Biologics Södertälje

Cobra Biologics Sites Keele: Virus and Small Scale Microbial Södertälje: Mammalian Cell Culture (Monoclonal antibody, recombinant proteins) Now: Modern facility, with non- GMP and GMP 250L SUB Comprehensive analytics and cell line development capability Future: 1,000L disposable SUB for commercial capacity Now: 14 year track record of developing processes and GMP manufacturing for pioneering medicines Future: Commercial virus capacity 250L disposable SUB Matfors: Fill Finish and Large Scale Microbial Now: 20 year track record for clinical and commercial supply with 600L microbial GMP capacity. New aseptic fill/ finish facility including lyophilisation Future: Expansion space for fill/finish or bio-production

Product Areas Proteins Bacteria Plasmids Bacteriophages Whole cells Animal cells Viruses Proteins Novel proteins Monoclonal antibodies

Goals and Drivers Our goals to meet customer requirements Increase flexibility for different molecules and different technologies Decrease time lines and start up times Increase the GMP capacity Potential drivers for early stage clinical development programmes Productivity & cost of goods Rapid generation of clinical materials & obtaining clinical data Development costs Product quality Regulatory expectations

Platform Strategy for Customer Projects Customer project Cell line development Process development Supply of Material (tox) GMP Production Cello Plates Shake flasks Culti flasks Ambr Micro Bioreactors Shake flasks Culti flasks 5L BR 25L Wave 50L SUB 250L SUB 25L Wave 250L SUB 100L SS Media, feed and buffer preparation using single use bags Utilization of singles use materials increases flexibility and reliability of the processes used as part of the cell culture platform strategy

Cell Line Development and Small Scale Process Development Transfection and clone selection High throughput colony detection, titre determination and scale up in static culture using Cello Robotic System Second titre screen in shake flask culture Small scale cultivation Shake flasks Up to 1L Culti flasks Small volumes (8-12 ml) Easy handling Results comparable to shake flasks Micro Bioreactors Ambr Micro Bioreactor system

Cello Robotic System for Cell Line Development Plate handling robot (Stäubli) Up to three incubators and a cold storage unit Two pipetting robots High resolution microscope Software, managing the complete process from clone screening to expansion to 6 well plates Database with full traceability for each clone Cello Robotic System manufactured by TAP Biosystems

Material Supply at Different Scales Delivery of a requested amount of material for purification or analytical development or toxicological studies Delivery of GMP-material for pre-clinical supply Material from clonal cell lines or cell pools Fed-batch, batch or perfusion Supply of material from a certain scale Shake flask 2x Wave (5-25L) 2x 50L SUB (25-50L) 250L SUB (125-250L) Supply of material in 250L scale Scale up in Shake flask Seed train using Wave Production in 250L SUB

Single Use Bioreactors Less cleaning and no cleaning verification needed Time is saved between batches, quicker re-start and shorter lead times Flexible systems Less complex Easy to train personnel Reduced risk for contamination Easy to clean, less sanitation agent Compatible with excising clarification equipment Seamless transfer from lab to GMP production Similar equipment

GMP Supply Time Line 1 w 2.5 w 2 w Set-up and cleaning Scale up and Production in 100L SS Cleaning and cleaning verification One slot is 5.5 w 1 day 3 days 2 w 1 day Scale up Wave Set up Production in 250 L SUB Cleaning One slot is 3 w Since less cleaning and no cleaning verifications are needed a new project can be started directly if the scale up is done in parallel.

Implementation of Ambr Micro Bioreactor System

Need for an Automatic System for Process Development Why did we need an automatic system? Keep time lines short and speeding up the development work More information from one round of process development Reduce costs by reduced work Improve quality of process development Bioreactor process parameters evaluated early in a project Comparable to bioreactor results Limitations in comparability between shake flasks and bioreactors

Screen of market for Micro Bioreactor Systems Requirements Measure and control ph (CO2 and Base) Measure and control DO (Air/O2) Add and take out liquid Simple to handle, not to complex Sufficient culture volume Experiment capacity Process economy Only a few systems on the market Complexity/simplicity Expensiveness Volumetric challenges System capacity

Ambr Micro Bioreactor System 24 single use bioreactors 24 experiments in parallell Individually controlled ph and DO Stirring and temperature control Automated sampling and additions Screening of process parameters Media, nutrition feeds, clones Process parameter optimization ph, DO, temperature etc Ambr Micro Bioreactor System Manufactured by TAP Biosystems

Ambr Micro Bioreactor System Single use bioreactors Optical DO and ph measurements 10-15 ml culture volume Stirrer Dip tube for gassing (CO 2, N 2, O 2 ) Benefits Suitable for design of experiment setups Large amount of data achieved Quick and easy to set up No cleaning Small footprint in the lab Low volumes of media and feed required Single use bioreactor

Implementation of Ambr Micro Bioreactor System Timeline Purchase in May 2011 First run through in May 2011 Implemented in internal projects in June 2011 Successfully used in first customer project in July 2011 Results Comparable to previous results in 5L scale bioreactors Large amount of data for evaluation Quick and easy to set up ph and DO regulation sufficient

Titer (g/l) Case study; Process Development 2,5 2 Media screening Un-optimized batch Feed Screen using Ambr 1 st Round of Feed Optimization using Ambr 1,5 1 0,5 Media screening Performed in culti flasks (12 ml) Feed Screen Performed in Ambr using one base media 1 st round of feed optimisation DoE set-up for selected feed using Ambr 0 Un-optimized Batch Feed Screen Ambr Feed Optimization Ambr Commercially available chemically defined media and feeds 2 g/l IgG achieved after 1 round of feed optimization In total 6 weeks of process development after clone selection

Viable Cell Density [MVC/mL] Viability [%] Cell density [MVC/mL] Viability [%] Results using Ambr Micro Bioreactor system Growth in Ambr and 5L glass bioreactor are comparable Growth in 5L glass bioreactor and 250L SUB are comparable 250 L Ambr 5L BR 5 L Culture time [days] Culture time [days]

Data Data Clean Clean Clean Clean Clean Clean 2v Shortened Process Development Time Line Parameter optimization in BR 18v 2v 24 SH 4x 5L 4x 5L 4x 5L 4x 5L 4x 5L 4x 5L 2x 5L Clone selection 24x MBR 24x MBR 2x 5L Process verification in BR 2v 2v 2v Clone selection can be performed in micro bioreactors More valid results, comparable to bioreactor Parameter optimization in 24 set-ups Evaluation in 2 weeks using Ambr micro bioreactors No cleaning between batches, quick start-up Evaluation in 18 weeks using 5L glass bioreactors 4 BR in parallel using 1 FTE Process verification in small scale bioreactor (2-5L)

Data Data Data Data Data Data Increased Process Development Capacity 2v 5-6 weeks of process development in BR 2v 24 SH 4x 5L 4x 5L 2x 5L Clone selection Process verification in BR 24x MBR 24x MBR 24x MBR 2x 5L 2v 2v 2v 2v Evaluation of different media, feeds, feeding strategies and process parameters Increased number of set-ups increases the ability to find a suitable process 5-6 weeks of process development with 1 FTE Ability to test 8 different set-ups in 5L bioreactor scale Ability to test 48 different set-ups using Ambr

Challenges Culture volume should be kept within 10-15 ml Processes are designed to fit the volume Feed volume restrictions Base and glucose additions predicted in advance to estimate culture volume Sampling volumes must be kept small Daily sampling for metabolites, ph, pco2 and cell count Small volumes are used for all analyses Samples for titer and spent media analysis Analysis methods for titer and amino acid concentrations set up in 96-well format Addition of antifoam necessary Foaming occurs if no anti-foam is added ph control A tight deadband might cause high usage of tips and high addition of base Optimization of data handling during and after run Great amount of data in excel sheets ph and DO curves

Future Improvements using Ambr Compare results from Ambr and 250L SUB in order to evaluate the possibility to further reduce time lines Include Ambr even earlier in cell line development platform to select clones based on bioreactor performance earlier

Summary The Ambr Micro Bioreactor system was successfully implemented during 2011 Ambr is included in our process development platform for customer projects Ambr results are comparable to results from 5L bioreactor scale